The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 22,419 | 831,267 | SH | SOLE | 831,267 | 0 | 0 | ||
| AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 4,725 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 52,601 | 1,595,911 | SH | SOLE | 1,595,911 | 0 | 0 | ||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 33,830 | 970,164 | SH | SOLE | 970,164 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 13,847 | 168,500 | SH | SOLE | 168,500 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 11,001 | 446,641 | SH | SOLE | 446,641 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 26,688 | 569,414 | SH | SOLE | 569,414 | 0 | 0 | ||
| CARDIFF ONCOLOGY INC | COM | 14147L108 | 6,545 | 982,753 | SH | SOLE | 982,753 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 41,108 | 761,398 | SH | SOLE | 761,398 | 0 | 0 | ||
| CENTURY THERAPEUTICS INC | COM | 15673T100 | 15,162 | 602,623 | SH | SOLE | 602,623 | 0 | 0 | ||
| CONNECT BIOPHARMA HLDGS LTD | ADS | 207523101 | 7,795 | 326,143 | SH | SOLE | 326,143 | 0 | 0 | ||
| CURIS INC | COM NEW | 231269200 | 17,968 | 2,294,721 | SH | SOLE | 2,294,721 | 0 | 0 | ||
| CYTEK BIOSCIENCES INC | COM | 23285D109 | 10,705 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| DESIGN THERAPEUTICS INC | COM | 25056L103 | 219 | 14,926 | SH | SOLE | 14,926 | 0 | 0 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 9,478 | 583,649 | SH | SOLE | 583,649 | 0 | 0 | ||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 830 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| GOSSAMER BIO INC | COM | 38341P102 | 19,020 | 1,513,138 | SH | SOLE | 1,513,138 | 0 | 0 | ||
| HELIX ACQUISITION CORP | COM CL A | G4444C102 | 3,948 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| I MAB | SPONSORED ADS | 44975P103 | 55,416 | 764,461 | SH | SOLE | 764,461 | 0 | 0 | ||
| IKENA ONCOLOGY INC | COM | 45175G108 | 3,471 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 4,499 | 277,057 | SH | SOLE | 277,057 | 0 | 0 | ||
| JIYA ACQUISITION CORP | COM CL A | 47760M102 | 2,934 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 3,342 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 4,204 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| OMEGA THERAPEUTICS INC | COMMON STOCK | 68217N105 | 6,980 | 370,279 | SH | SOLE | 370,279 | 0 | 0 | ||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 2,984 | 100,141 | SH | SOLE | 100,141 | 0 | 0 | ||
| PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 4,742 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| STOKE THERAPEUTICS INC | COM | 86150R107 | 7,551 | 296,822 | SH | SOLE | 296,822 | 0 | 0 | ||
| TENAX THERAPEUTICS INC | COM NEW | 88032L209 | 54 | 30,600 | SH | SOLE | 30,600 | 0 | 0 | ||
| VERA THERAPEUTICS INC | CL A | 92337R101 | 12,078 | 696,126 | SH | SOLE | 696,126 | 0 | 0 | ||